Valitor Expands Leadership Team with Appointment of Omkar Joshi, Ph.D. as Vice President of CMC
July 19, 2023 16:00 ET
|
Valitor, Inc.
BERKELEY, Calif., July 19, 2023 (GLOBE NEWSWIRE) -- Valitor, a biotechnology company engineering better medicines to conquer drug limitations, today announced the appointment of Omkar Joshi,...
Valitor Presents Preclinical Data on its Long-acting Anti-VEGF Biologic in Development for Durable Treatment of Wet AMD at the Association for Research in Vision and Ophthalmology Annual Meeting
April 24, 2023 18:00 ET
|
Valitor, Inc.
BERKELEY, Calif., April 24, 2023 (GLOBE NEWSWIRE) -- Valitor, a biotechnology company engineering better medicines to conquer drug limitations, today announced new data from VLTR-557, its...
Valitor to Present on the Potential for its Multivalent Polymer Technology to Expand the Therapeutic Index of Oncology Agents at the 2023 American Association for Cancer Research Annual Meeting
April 10, 2023 08:00 ET
|
Valitor, Inc.
BERKELEY, Calif., April 10, 2023 (GLOBE NEWSWIRE) -- Valitor, a biotechnology company engineering better medicines to conquer drug limitations, today announced that data reviewing the therapeutic...
Valitor to Present at the Association for Research in Vision and Ophthalmology Annual Meeting
March 23, 2023 08:00 ET
|
Valitor, Inc.
BERKELEY, Calif., March 23, 2023 (GLOBE NEWSWIRE) -- Valitor, a biotechnology company engineering better medicines to conquer drug limitations, today announced that two abstracts have been accepted...
Valitor Announces Presentation on Novel Anti-VEGF Antibody Conjugate and Multivalent Polymer Technology Platform at Upcoming Ophthalmology Innovation Source (OIS) Summit
December 01, 2022 16:00 ET
|
Valitor, Inc.
BERKELEY, Calif., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Valitor, a biotechnology company engineering better medicines to conquer drug limitations, today announced that its president and chief scientific...
Valitor Announces the Closing of its Series B Financing and Names Steven Lo as Chief Executive Officer
October 05, 2022 08:00 ET
|
Valitor, Inc.
BERKELEY, Calif., Oct. 05, 2022 (GLOBE NEWSWIRE) -- Valitor, a biotechnology company engineering better medicines to conquer drug limitations, today announced that it has closed a Series B...